Zobrazeno 1 - 10
of 538
pro vyhledávání: '"Erice, O."'
Autor:
Entrialgo-Cadierno R; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Cueto-Ureña C; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Welch C; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain., Feliu I; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Macaya I; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Vera L; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Morales X; Imaging Unit and Cancer Imaging Laboratory, University of Navarra, CIMA, Pamplona, Spain., Michelina SV; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy., Scaparone P; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy., Lopez I; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Darbo E; University of Bordeaux, INSERM, BRIC, Bordeaux, 1312, F‑33000, France., Erice O; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Vallejo A; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Moreno H; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain., Goñi-Salaverri A; Molecular Therapies Program, University of Navarra, CIMA, Pamplona, Spain., Lara-Astiaso D; Molecular Therapies Program, University of Navarra, CIMA, Pamplona, Spain.; Wellcome - MRC Cambridge Stem Cell Institute (CSCI), Cambridge, UK., Halberg N; Department of Biomedicine, University of Bergen, Bergen, Norway., Cortes-Dominguez I; Imaging Unit and Cancer Imaging Laboratory, University of Navarra, CIMA, Pamplona, Spain.; Bioinformatics Platform, University of Navarra, CIMA, Pamplona, Spain., Guruceaga E; Bioinformatics Platform, University of Navarra, CIMA, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy., Lecanda F; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain., Vicent S; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain. silvevicent@unav.es.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. silvevicent@unav.es.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. silvevicent@unav.es.; Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain. silvevicent@unav.es.
Publikováno v:
Molecular cancer [Mol Cancer] 2023 Jun 16; Vol. 22 (1), pp. 97. Date of Electronic Publication: 2023 Jun 16.
Autor:
Entrialgo-Cadierno R; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Cueto-Ureña C; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Welch C; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Feliu I; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Macaya I; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Vera L; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Morales X; Imaging Unit and Cancer Imaging Laboratory, University of Navarra, CIMA, Pamplona, Spain., Michelina SV; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy., Scaparone P; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy., Lopez I; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Darbo E; University of Bordeaux, INSERM, BRIC, U 1312, F-33000, Bordeaux, France., Erice O; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Vallejo A; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Moreno H; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain., Goñi-Salaverri A; Molecular Therapies Program, University of Navarra, CIMA, Pamplona, Spain., Lara-Astiaso D; Molecular Therapies Program, University of Navarra, CIMA, Pamplona, Spain.; Wellcome - MRC Cambridge Stem Cell Institute (CSCI), Cambridge, UK., Halberg N; Department of Biomedicine, University of Bergen, Bergen, Norway., Cortes-Dominguez I; Imaging Unit and Cancer Imaging Laboratory, University of Navarra, CIMA, Pamplona, Spain.; Bioinformatics Platform, University of Navarra, CIMA, Pamplona, Spain., Guruceaga E; Bioinformatics Platform, University of Navarra, CIMA, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy., Lecanda F; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain., Vicent S; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain. silvevicent@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. silvevicent@unav.es.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. silvevicent@unav.es.; Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain. silvevicent@unav.es.
Publikováno v:
Molecular cancer [Mol Cancer] 2023 May 20; Vol. 22 (1), pp. 86. Date of Electronic Publication: 2023 May 20.
Autor:
Erice O; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Narayanan S; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain., Feliu I; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain., Entrialgo-Cadierno R; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain., Malinova A; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Vicentini C; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Guruceaga E; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; University of Navarra, Center for Applied Medical Research, Computational Biology Program, Pamplona, Spain., Delfino P; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Trajkovic-Arsic M; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany., Moreno H; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain., Valencia K; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Blanco E; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain., Macaya I; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain., Öhlund D; Department of Radiation Sciences, Umeå University, Umeå, Sweden.; Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden., Khatri P; Stanford Institute for Immunity, Transplantation and Infection, Stanford, California.; Stanford Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, California., Lecanda F; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Pathology, Anatomy, and Physiology, University of Navarra, Pamplona, Spain., Scarpa A; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.; ARC-Net Research Center, University of Verona, Verona, Italy., Siveke JT; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site University Hospital Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany., Corbo V; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Ponz-Sarvise M; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain., Vicent S; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Pathology, Anatomy, and Physiology, University of Navarra, Pamplona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Mar 14; Vol. 29 (6), pp. 1137-1154.
Autor:
Landa Magdalena, A., Rodrigues, P.M., Erice, O., Paiva, N.A., Fernandez-Barrena, M.G., Olaizola, P., Lapitz, A., O'Rourke, C.J., Andersen, J.B., Calvisi, D.F., Azkargorta, M., Elortza, F., Goicoechea, I., Lawrie, C.H., Bujanda, L., Perugorria, M.J., Bañales, J.M.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S225-S225
Autor:
Vallejo A; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain., Erice O; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Entrialgo-Cadierno R; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain., Feliu I; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain., Guruceaga E; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; University of Navarra, Centre for Applied Medical Research, Computational Biology Program, Pamplona, Spain; ProteoRed-Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Perugorria MJ; University of the Basque Country, San Sebastian, Spain; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital -, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain., Olaizola P; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital -, University of the Basque Country (UPV/EHU), San Sebastian, Spain., Muggli A; Institute of Pathology, University of Regensburg, Regensburg, Germany., Macaya I; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain., O'Dell M; University of Rochester Medical Centre, Rochester, NY, USA., Ruiz-Fernandez de Cordoba B; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain., Ortiz-Espinosa S; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain., Hezel AF; University of Rochester Medical Centre, Rochester, NY, USA., Arozarena I; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Lecanda F; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC, Instituto de Salud Carlos III), Madrid, Spain; University of Navarra, Department of Pathology, Anatomy and Physiology, Pamplona, Spain., Avila MA; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain; University of Navarra, Centre for Applied Medical Research, Hepatology Program, Pamplona, Spain., Fernandez-Barrena MG; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain; University of Navarra, Centre for Applied Medical Research, Hepatology Program, Pamplona, Spain., Evert M; Institute of Pathology, University of Regensburg, Regensburg, Germany., Ponz-Sarvise M; Clinica Universidad de Navarra, Department of Medical Oncology, Pamplona, Spain., Calvisi DF; Institute of Pathology, University of Regensburg, Regensburg, Germany., Banales JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital -, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain; Ikerbasque, Basque Foundation for Sciences, Bilbao, Spain., Vicent S; University of Navarra, Centre for Applied Medical Research, Program in Solid Tumours, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC, Instituto de Salud Carlos III), Madrid, Spain; University of Navarra, Department of Pathology, Anatomy and Physiology, Pamplona, Spain. Electronic address: silvevicent@unav.es.
Publikováno v:
Journal of hepatology [J Hepatol] 2021 Aug; Vol. 75 (2), pp. 363-376. Date of Electronic Publication: 2021 Apr 20.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Egerer, Mara1 (AUTHOR) mara.egerer@charite.de, Schuch, Kathrin2 (AUTHOR) kitti.schuch@gmail.com, Schöler, David2 (AUTHOR) david.schoeler@med.uni-duesseldorf.de, Artusa, Fabian1 (AUTHOR) fabian.artusa@charite.de, Püngel, Tobias1,3 (AUTHOR) tobias.puengel@charite.de, Holtman, Theresa Maria1 (AUTHOR) theresa.holtmann@charite.de, Loosen, Sven H.2 (AUTHOR) sven.loosen@med.uni-duesseldorf.de, Demir, Münevver1 (AUTHOR) muenevver.demir@charite.de, Wree, Alexander1 (AUTHOR) alexander.wree@charite.de, Luedde, Tom2 (AUTHOR) tom.luedde@med.uni-duesseldorf.de, Tacke, Frank1 (AUTHOR) frank.tacke@charite.de, Roderburg, Christoph2 (AUTHOR) christoph.roderburg@med.uni-duesseldorf.de, Mohr, Raphael1 (AUTHOR) raphael.mohr@charite.de
Publikováno v:
Cancers. Nov2024, Vol. 16 Issue 21, p3651. 13p.
Autor:
Valencia K; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; University of Navarra, Department of Biochemistry and Genetics, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Erice O; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain., Kostyrko K; Division of Hematology and Oncology, UCSF, San Francisco, California, USA., Hausmann S; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Guruceaga E; Bioinformatics Platform, Center for Applied Medical Research, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Tathireddy A; Department of Pediatrics, and., Flores NM; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sayles LC; Division of Hematology and Oncology, UCSF, San Francisco, California, USA., Lee AG; Division of Hematology and Oncology, UCSF, San Francisco, California, USA., Fragoso R; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Sun TQ; Achelois Oncology, Redwood City, California, USA., Vallejo A; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; University of Navarra, Department of Pathology, Anatomy and Physiology, Pamplona, Spain., Roman M; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; University of Navarra, Department of Pathology, Anatomy and Physiology, Pamplona, Spain., Entrialgo-Cadierno R; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; University of Navarra, Department of Biochemistry and Genetics, Pamplona, Spain., Migueliz I; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain., Razquin N; University of Navarra, Center for Applied Medical Research, Program in Gene Therapy and Regulation of Gene Expression, Pamplona, Spain., Fortes P; University of Navarra, Center for Applied Medical Research, Program in Gene Therapy and Regulation of Gene Expression, Pamplona, Spain., Lecanda F; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; University of Navarra, Department of Pathology, Anatomy and Physiology, Pamplona, Spain., Lu J; Genetics Department, Yale University, New Haven, Connecticut, USA., Ponz-Sarvise M; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; Clínica Universidad de Navarra, Department of Medical Oncology, Pamplona, Spain., Chen CZ; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.; Achelois Oncology, Redwood City, California, USA., Mazur PK; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sweet-Cordero EA; Division of Hematology and Oncology, UCSF, San Francisco, California, USA., Vicent S; University of Navarra, Center for Applied Medical Research, Program in Solid Tumors, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; University of Navarra, Department of Pathology, Anatomy and Physiology, Pamplona, Spain.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2020 Apr 01; Vol. 130 (4), pp. 1879-1895.
Autor:
Porreca, Veronica1 (AUTHOR) corbella.2016275@studenti.uniroma1.it, Barbagallo, Cristina2 (AUTHOR) cbarbagallo@unict.it, Corbella, Eleonora1 (AUTHOR) peres.1461165@studenti.uniroma1.it, Peres, Marco1 (AUTHOR), Stella, Michele2 (AUTHOR) michelestella7@gmail.com, Mignogna, Giuseppina3 (AUTHOR) pina.mignogna@uniroma1.it, Maras, Bruno3 (AUTHOR) bruno.maras@uniroma1.it, Ragusa, Marco2 (AUTHOR) mragusa@unict.it, Mancone, Carmine1 (AUTHOR) veronica.porreca@uniroma1.it
Publikováno v:
Cancers. Aug2024, Vol. 16 Issue 16, p2889. 40p.
Autor:
Shen, Shizhen1,2 (AUTHOR), Wang, Conghui2 (AUTHOR), Gu, Jiaxin1 (AUTHOR), Song, Feifei1 (AUTHOR), Wu, Xiaodong2 (AUTHOR), Qian, Fangfang1 (AUTHOR), Chen, Xiaojing1 (AUTHOR), Wang, Lingfang1 (AUTHOR), Peng, Qiaohua2 (AUTHOR), Xing, Ziyu1 (AUTHOR), Gu, Lingkai1 (AUTHOR), Wang, Fenfen1,2 (AUTHOR) wangfenfen@zju.edu.cn, Cheng, Xiaodong1,2 (AUTHOR) chengxd@zju.edu.cn
Publikováno v:
Journal of Extracellular Vesicles. Aug2024, Vol. 13 Issue 8, p1-19. 19p.